InvestorsHub Logo
Followers 27
Posts 1115
Boards Moderated 0
Alias Born 06/10/2017

Re: None

Tuesday, 07/27/2021 5:13:54 PM

Tuesday, July 27, 2021 5:13:54 PM

Post# of 682078

Researchers at UCLA developed the first personalized vaccine for brain tumors (dendritic cell-based vaccine, or DCVax®). DCVax® has extended survival of many of our glioblastoma patients for more than a year, and some are thriving more than 10 years after their initial diagnosis.




https://www.uclahealth.org/braintumor/biologics
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News